MarketCap
Facebook
X
TelegramQuarterly report 2025-Q4
added 01-08-2026
Neogen Corporation Long Term Debt Current 2011-2026 | NEOG
Annual Long Term Debt Current Neogen Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 5.64 M | 5.1 M | 3.28 M | 1.44 M | 1.28 M | 1.05 M | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 5.64 M | 1.05 M | 2.97 M |
Long Term Debt Current of other stocks in the Diagnostics research industry
| Issuer | Long Term Debt Current | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
2.18 M | - | -6.23 % | $ 30.6 M |  Germany |
|
Akumin
AKU
|
17.2 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Brainsway Ltd.
BWAY
|
824 K | $ 24.58 | 1.91 % | $ 99.4 M |  Israel |
 |
BioNano Genomics
BNGO
|
2.99 M | $ 1.12 | -0.88 % | $ 1.42 M |  USA |
 |
Aspira Women's Health
AWH
|
77 K | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
829 K | - | -61.36 % | $ 2.46 M | USA |
 |
Celcuity
CELC
|
172 K | $ 106.01 | 0.82 % | $ 4.18 B | USA |
 |
Biocept
BIOC
|
518 K | - | -13.05 % | $ 7.29 M | USA |
 |
Check-Cap Ltd.
CHEK
|
264 K | - | - | $ 9.42 M | Israel |
 |
Chembio Diagnostics
CEMI
|
915 K | - | 0.22 % | $ 16.8 M | USA |
 |
DarioHealth Corp.
DRIO
|
111 K | $ 11.26 | - | $ 319 M | Israel |
 |
Enzo Biochem
ENZ
|
841 K | - | -8.98 % | $ 14.8 K | USA |
 |
Co-Diagnostics
CODX
|
838 K | - | - | $ 79.8 M | USA |
 |
Global Cord Blood Corporation
CO
|
147 K | - | - | $ 399 M |  China |
 |
Fulgent Genetics
FLGT
|
1.44 M | $ 23.02 | 0.04 % | $ 696 M | USA |
 |
Genetic Technologies Limited
GENE
|
264 K | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
21.5 M | - | 0.12 % | $ 80.1 M | China |
 |
Quest Diagnostics Incorporated
DGX
|
173 M | $ 209.34 | 0.95 % | $ 23.2 B | USA |
 |
Castle Biosciences
CSTL
|
1.66 M | $ 30.02 | 3.73 % | $ 834 M | USA |
 |
CareDx, Inc
CDNA
|
5.94 M | $ 19.18 | 2.08 % | $ 1.03 B | USA |
 |
Danaher Corporation
DHR
|
199 M | $ 209.79 | -0.58 % | $ 153 B | USA |
 |
DermTech
DMTK
|
3.07 M | - | -11.32 % | $ 2.94 M | USA |
 |
DexCom
DXCM
|
21.6 M | $ 72.99 | -0.38 % | $ 28.5 B | USA |
 |
Interpace Biosciences
IDXG
|
383 K | $ 1.74 | -5.95 % | $ 7.63 M | USA |
 |
Exact Sciences Corporation
EXAS
|
33.6 M | $ 103.46 | 0.07 % | $ 19.5 B | USA |
 |
Guardant Health
GH
|
27.7 M | $ 96.45 | 2.15 % | $ 12.1 B | USA |
 |
QIAGEN N.V.
QGEN
|
23.4 M | - | - | $ 10.6 B |  Niderland |
 |
Laboratory Corporation of America Holdings
LH
|
191 M | $ 287.1 | 0.62 % | $ 24.1 B | USA |
 |
Charles River Laboratories International
CRL
|
57.7 M | $ 166.77 | 1.98 % | $ 8.27 B | USA |
 |
Heska Corporation
HSKA
|
2.94 M | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
475 K | - | -20.0 % | $ 1.06 M | USA |
 |
ICON Public Limited Company
ICLR
|
24.3 M | $ 104.81 | 0.14 % | $ 8.65 B |  Irlanda |
 |
ENDRA Life Sciences
NDRA
|
96.9 K | $ 3.77 | 0.53 % | $ 2.02 M | USA |
 |
IDEXX Laboratories
IDXX
|
27.1 M | $ 648.66 | 4.1 % | $ 52.2 B | USA |
 |
Illumina
ILMN
|
79 M | $ 123.46 | 2.42 % | $ 19.6 B | USA |
 |
IQVIA Holdings
IQV
|
93 M | $ 164.94 | 1.75 % | $ 28.4 B | USA |
 |
Motus GI Holdings
MOTS
|
169 K | - | -34.28 % | $ 263 K | Israel |
 |
Koninklijke Philips N.V.
PHG
|
241 M | $ 31.48 | 0.82 % | $ 20 B | Niderland |
 |
Mettler-Toledo International
MTD
|
35.1 M | $ 1 382.99 | -0.81 % | $ 28.5 B |  Schweiz |
|
Biodesix
BDSX
|
719 K | $ 13.28 | 3.99 % | $ 1.72 B | USA |
 |
Natera
NTRA
|
7.64 M | $ 209.72 | 0.18 % | $ 20.6 B | USA |
 |
Lantheus Holdings
LNTH
|
1.87 M | $ 73.43 | 0.01 % | $ 5.08 B | USA |
 |
Biomerica
BMRA
|
358 K | $ 2.11 | 0.49 % | $ 4.85 M | USA |
 |
Bioventus
BVS
|
4.06 M | $ 8.71 | 0.58 % | $ 546 M | USA |
 |
Medpace Holdings
MEDP
|
23.2 M | $ 442.92 | -0.46 % | $ 12.8 B | USA |